Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock, Common [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Unallocated Common Share Held By ESOP [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock Outstanding [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Unallocated Common Share Held By ESOP [Member]
Total
Balance (in shares) at Dec. 31, 2021               0              
Balance at Dec. 31, 2021                 $ 0 $ 0 $ 0 $ 45,264 $ (81) $ 0 $ 45,183
Net income (losses)                 0 0 0 (130) 0 0 (130)
ESOP shares committed to be released                 0 0 16 0 0 87 103
Change in net unrealized loss on securities available for sale, net                 0 0 0 0 (7,774) 0 (7,774)
Proceeds of stock offering and issuance of common shares (net of issuance costs of $2.5 million) (in shares)               5,290,000              
Proceeds of stock offering and issuance of common shares (net of issuance costs of $2.5 million)                 53 0 49,387 0 0 0 49,440
Issuance of common shares donated to the NSTS Charitable Foundation (in shares)               107,959              
Issuance of common shares donated to the NSTS Charitable Foundation                 1 0 1,008 0 0 0 1,009
Purchase of common shares by the ESOP (431,836 shares)                 0 0 0 0 0 (4,319) (4,319)
Balance (in shares) at Jun. 30, 2022               5,397,959              
Balance at Jun. 30, 2022                 54 0 50,411 45,134 (7,855) (4,232) 83,512
Balance (in shares) at Mar. 31, 2022               5,397,959              
Balance at Mar. 31, 2022                 54 0 50,405 44,985 (4,544) (4,275) 86,625
Net income (losses)                 0 0 0 149 0 0 149
ESOP shares committed to be released                 0 0 6 0 0 43 49
Change in net unrealized loss on securities available for sale, net                 0 0 0 0 (3,311) 0 (3,311)
Balance (in shares) at Jun. 30, 2022               5,397,959              
Balance at Jun. 30, 2022                 54 0 50,411 45,134 (7,855) (4,232) 83,512
Balance (in shares) at Dec. 31, 2022               5,397,959              
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 $ 0 $ 0 $ 0 $ (279) $ 0 $ 0 $ (279)                
Balance at Dec. 31, 2022                 54 0 50,420 45,291 (11,125) (4,098) 80,542
Net income (losses)                 0 0 0 44 0 0 44
ESOP shares committed to be released                 0 0 (6) 0 0 108 102
Change in net unrealized loss on securities available for sale, net                 0 0 0 0 294 0 $ 294
Purchase of treasury stock from stock repurchase program (in shares)               (74,295)             (74,295)
Purchase of treasury stock from stock repurchase program                 0 (649) 0 0 0 0 $ (649)
Compensation cost for stock options and restricted stock                 0 0 28 0 0 0 28
Issuance of common shares for the restricted stock plan (in shares)               187,200              
Issuance of common shares for the restricted stock plan                 2 0 (2) 0 0 0 0
Balance (in shares) at Jun. 30, 2023               5,510,864              
Balance at Jun. 30, 2023                 56 (649) 50,440 45,056 (10,831) (3,990) 80,082
Balance (in shares) at Mar. 31, 2023               5,397,959              
Balance at Mar. 31, 2023                 54 0 50,421 45,182 (9,544) (4,044) 82,069
Net income (losses)                 0 0 0 (126) 0 0 (126)
ESOP shares committed to be released                 0 0 (7) 0 0 54 47
Change in net unrealized loss on securities available for sale, net                 0 0 0 0 (1,287) 0 (1,287)
Purchase of treasury stock from stock repurchase program (in shares)               (74,295)              
Purchase of treasury stock from stock repurchase program                 0 (649) 0 0 0 0 (649)
Compensation cost for stock options and restricted stock                 0 0 28 0 0 0 28
Issuance of common shares for the restricted stock plan (in shares)               187,200              
Issuance of common shares for the restricted stock plan                 2 0 (2) 0 0 0 0
Balance (in shares) at Jun. 30, 2023               5,510,864              
Balance at Jun. 30, 2023                 $ 56 $ (649) $ 50,440 $ 45,056 $ (10,831) $ (3,990) $ 80,082